IP Library Patent Application 12238094
Patent Application
App. No. 12/238,094

Invisible Power Port ID Tattoo

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/238,094
Abstract

A solution for use in medical procedures, comprises including a plurality of microspheres holding a fluorescent dye reactive to ultraviolet light and a base dye which, under white light, has one of a color substantially matching a color of a target portion of skin into which it is to be injected and which has, under UV light, a color slightly darker than a color of the target portion of skin. A method comprises identifying a target area of the skin to be accessed in a medical procedure and injecting into at least a portion of the target area a solution including a plurality of microspheres holding a colored dye and a fluorescent dye reactive to ultraviolet light in combination with locating the target area by illuminating the skin with ultraviolet light.

Claims (23)

1 . A solution for use in medical procedures comprising a plurality of microspheres, the microspheres holding a first dye reactive to ultraviolet light and a second dye which, under white light has one of a color substantially matching a color of a target portion of a patient's skin into which it is to be injected and, under ultraviolet light, has a color different than a color of the target portion of skin.

2 . The solution according to claim 1 , wherein at least a portion of the microspheres comprise polymethylmethacrylate.

3 . The solution according to claim 1 , wherein the first dye is encapsulated in a fluid tight polymer sealed to fluid flow, the encapsulated first dye being suspended in the second dye.

4 . The solution according to claim 1 , wherein the microspheres are formed of a material non-reactive with the skin.

5 . The solution according to claim 1 , wherein at least a portion of the microspheres include a filler of one of air, a perfluorocarbon gas and nitrogen.

6 . The solution according to claim 5 , wherein the filler material is reactive to ultraviolet light.

7 . The solution according to claim 5 , wherein the filler material is reactive to ultrasonic waves.

8 . The solution according to claim 1 , wherein the dye is separated from red blood cells of the target portion of skin by a wall of the microsphere.

9 . The solution according to claim 1 , wherein the second dye is darker than the target portion of the patient's skin.

10 . A method, comprising:

identifying a target area of a patient's skin to be accessed in a medical procedure;

injecting into at least a portion of the target area a solution including a plurality of microspheres, the microspheres comprising a phosphorescent dye, reactive under a predetermined wavelength of ultraviolet light, encapsulated by a material which does not absorb ultraviolet light; and

locating the target area by illuminating the skin with ultraviolet light.

11 . The method of claim 10 , wherein the target area is a subcutaneous region of interest.

12 . The method of claim 11 , wherein the subcutaneous region of interest includes one or both of an implanted device and a subcutaneous portion of tissue to be treated.

13 . The method of claim 10 , further comprising inserting a therapeutic device into the target area to perform a therapeutic procedure.

14 . A method, comprising:

identifying a target area of the skin to be accessed in a medical procedure;

injecting into at least a portion of the target area a solution including a plurality of microspheres holding a gas reactive to ultrasonic waves; and

locating the target area by passing ultrasound energy through the skin until a pattern indicative of the presence of the gas containing microspheres is identified.

15 . The method of claim 14 , wherein the gas is one of air, a perfluorocarbon gas and nitrogen.

16 . The method of claim 14 , wherein the target area is a subcutaneous region of interest.

17 . The method of claim 16 , wherein the subcutaneous region of interest includes one of an implanted device and a portion of subcutaneous tissue to be treated.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2018
From: NAVILYST MEDICAL, INC.
To: ANGIODYNAMICS, INC.
Reel/Frame 047336/0558 →
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NAVILYST MEDICAL, INC.
Reel/Frame 040614/0834 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2013
From: JPMORGAN CHASE BANK N.A., AS ADMINISTRATIVE AGENT
To: NAVILYST MEDICAL, INC.
Reel/Frame 031315/0554 →
SECURITY AGREEMENT Recorded May 23, 2012
From: NAVILYST MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028260/0176 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2008
From: GRAY, JEFF; DUBAY, STEPHANIE; DICARLO, PAUL
To: NAMIC/VA, INC.
Reel/Frame 021612/0006 →
CHANGE OF NAME Recorded Sep 29, 2008
From: NAMIC/VA, INC.
To: NAVILYST MEDICAL, INC.
Reel/Frame 021612/0911 →